GlassScriptPhysician profile
Reynier Avon
NPI 1104370394
$16,921.46
in general payments reported to CMS, 2019-2025
23 companies · $5,118 in 2025
The $5,118 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,687 · 2022: $451 · 2023: $3,096 · 2024: $5,569 · 2025: $5,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $2,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,687.43 |
| Travel and Lodging | $2,095.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $6,022.50 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Zimmer Biomet Holdings, INC. | $4,726.42 | 2021-2024 | Sternalock Blu System, Sternalock 360 System, Advantagerib |
| Medtronic, INC. | $2,142.36 | 2022-2025 | Corevalve Evolut R, Mycarelink, Micra |
| Shockwave Medical, INC | $1,642.39 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $641.79 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $550.84 | 2021-2025 | Lifevest |
| Philips North America LLC | $235.44 | 2023-2025 | IV Other, Labosys |
| W. L. Gore & Associates, INC. | $235.15 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $160.96 | 2025 | Enroute Transcarotid Neuroprotection System |
| Glaxosmithkline, LLC. | $98.33 | 2021 | |
| Angiodynamics, INC. | $90.07 | 2021-2025 | Angiodynamics |
| Stryker Corporation | $54.32 | 2023-2025 | Flowtriever, Na |
| Bard Peripheral Vascular, INC. | $51.06 | 2025 | Venclose Maven Catheter, Venovo |
| Bayer Healthcare Pharmaceuticals INC. | $47.53 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $44.83 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $28.43 | 2024 | Onpattro |
| Aroa Biosurgery Incorporated | $26.61 | 2025 | |
| Bolton Medical INC | $25.63 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Asahi Intecc USA, INC. | $23.07 | 2025 | Asahi Peripheral Vascular Wires |
| Surmodics, INC. | $20.53 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy, Pounce Thrombectomy System |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $18.03 | 2025 | Keytruda |
| Chiesi USA, INC. | $15.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reynier Avon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.